Skip to search formSkip to main contentSkip to account menu

Sovaldi

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Some single-nucleotide polymorphisms (SNPs) in lipid organizers such as apolipoproteins and cell surface molecules… 
2018
2018
Background: Hepatitis C virus (HCV) is one of the hepatitis viruses that are transmitted through blоod or blоod products. HCV has… 
2015
2015
Both the Food and Drug Administration (FDA) and Harvoni and Sovaldi maker Gilead are warning Hepatitis C patients about serious… 
2015
2015
2014 was another banner year for public companies, building on the strength of 2013 and adding to the unprecedented biotech bull… 
2015
2015
Gilead Sciences set the price of its hepatitis C treatment sofosbuvir (marketed as Sovaldi) at $1000 a pill or $84 000 (£56 000… 
2015
2015
575 replication to cure infection [using] all-oral drug [combinations] without interferon,” says Jean-Michel Pawlotsky, of the… 
2013
2013
hepatitis C virus (HCV) drug was approved by the US Food and Drug Administration on 6 December, the specialist antiviral company…